BioAge Labs Management
Management criteria checks 2/4
BioAge Labs' CEO is Kristen Fortney, appointed in Apr 2015, has a tenure of 9.58 years. total yearly compensation is $1.38M, comprised of 35.7% salary and 64.3% bonuses, including company stock and options. directly owns 3.38% of the company’s shares, worth €21.43M. The average tenure of the management team and the board of directors is 3.8 years and 0.7 years respectively.
Key information
Kristen Fortney
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 35.7% |
| CEO tenure | 9.6yrs |
| CEO ownership | 3.4% |
| Management average tenure | 3.8yrs |
| Board average tenure | less than a year |
Recent management updates
No updates
Recent updates
No updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$71m |
| Jun 30 2024 | n/a | n/a | -US$62m |
| Mar 31 2024 | n/a | n/a | -US$66m |
| Dec 31 2023 | US$1m | US$493k | -US$64m |
Compensation vs Market: Kristen's total compensation ($USD1.38M) is about average for companies of similar size in the German market ($USD1.46M).
Compensation vs Earnings: Insufficient data to compare Kristen's compensation with company performance.
CEO
Kristen Fortney (41 yo)
9.6yrs
Tenure
US$1,382,720
Compensation
Dr. Kristen Fortney, PhD, serves as Member of Advisory Board at Known Medicine Inc. since April 2022. She co-founded BioAge Labs, Inc. in 2015 and serves as Chief Executive Officer, President, Treasurer, S...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.6yrs | US$1.38m | 3.38% € 21.3m | |
| Co-Founder | 4.5yrs | US$872.80k | 0.19% € 1.2m | |
| Chief Medical Officer & Executive VP of Research | 4.5yrs | US$840.83k | no data | |
| Chief Financial Officer | 3yrs | no data | 0.063% € 394.9k | |
| Vice President of Finance & Accounting | 3.6yrs | no data | no data | |
| Senior Vice President of Research | no data | no data | no data | |
| Senior Vice President of People | 2.8yrs | no data | no data | |
| Chief Business Officer & Therapeutic Area Head of Brain Aging | 5.7yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs | 4.8yrs | no data | no data | |
| Senior Vice President of Translational Aging Biology | 3.6yrs | no data | no data | |
| Chief Strategy Officer | 3.8yrs | no data | no data | |
| Chief Development Officer | 3yrs | no data | no data |
3.8yrs
Average Tenure
49.5yo
Average Age
Experienced Management: Y7G's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.6yrs | US$1.38m | 3.38% € 21.3m | |
| Co-Founder | 7.4yrs | US$872.80k | 0.19% € 1.2m | |
| Independent Director | less than a year | no data | no data | |
| Independent Chairman of the Board | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 7.4yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 3.3yrs | US$40.00k | 0% € 0 | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
0.7yrs
Average Tenure
59yo
Average Age
Experienced Board: Y7G's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.